Lannett Company Profile (NYSE:LCI)

About Lannett

Lannett logoLannett Company, Inc. develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The Company's products include Levothyroxine Sodium tablets, Digoxin tablets, Butalbital products, Ursodiol capsules and pain management products. Levothyroxine Sodium tablets are produced and marketed with around 12 varying potencies. Digoxin tablets are produced and marketed with approximately two different potencies. It distributes around three products containing Butalbital. Ursodiol capsules are produced and marketed in 300 milligram capsules. The Company offers a range of pain management products, such as Cocaine Topical Solution (C-Topical), Morphine Sulfate Oral Solution, Hydromorphone hydrochloric acid (HCl) tablets and Codeine Sulfate tablets.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: Pharmaceuticals
  • Exchange: NYSE
  • Symbol: LCI
  • CUSIP: 51601210
Key Metrics:
  • Previous Close: $34.23
  • 50 Day Moving Average: $30.82
  • 200 Day Moving Average: $24.25
  • Trailing P/E Ratio: 28.03
  • Foreward P/E Ratio: 8.89
  • P/E Growth: 0.50
  • Market Cap: $1.23B
  • Outstanding Shares: 36,604,000
  • Beta: 1.88
Additional Links:
Companies Related to Lannett:

Analyst Ratings

Consensus Ratings for Lannett (NYSE:LCI) (?)
Ratings Breakdown: 1 Sell Rating, 2 Hold Ratings, 4 Buy Ratings
Consensus Rating:Hold (Score: 2.43)
Consensus Price Target: $29.92 (12.60% downside)

Analysts' Ratings History for Lannett (NYSE:LCI)
DateFirmActionRatingPrice TargetDetails
8/24/2016Raymond James Financial Inc.Boost Price TargetOutperform$31.00 -> $43.00View Rating Details
7/12/2016Oppenheimer Holdings Inc.Reiterated RatingHoldView Rating Details
6/29/2016Deutsche Bank AGInitiated CoverageHold$26.00View Rating Details
3/25/2016SusquehannaLower Price Target$37.00 -> $30.00View Rating Details
3/25/2016Craig HallumLower Price TargetBuy$35.00View Rating Details
3/24/2016Roth CapitalLower Price TargetBuy$30.00 -> $27.50View Rating Details
3/24/2016Canaccord GenuityDowngradeBuy -> Sell$28.00 -> $18.00View Rating Details
(Data available from 8/29/2014 forward)


Earnings History for Lannett (NYSE:LCI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/23/2016Q416$0.59$0.73$161.55 million$168.90 millionViewListenView Earnings Details
5/3/2016Q316$0.63$0.75$160.49 million$163.70 millionViewN/AView Earnings Details
2/3/2016Q216$0.94$0.95$141.62 million$127.06 millionViewN/AView Earnings Details
11/4/2015Q116$0.89$0.99$103.90 million$106.40 millionViewN/AView Earnings Details
8/25/2015Q415$0.86$0.91$99.30 millionViewListenView Earnings Details
5/6/2015Q315$0.94$0.97$101.10 million$99.40 millionViewN/AView Earnings Details
2/4/2015Q215$1.06$1.21$102.95 million$114.80 millionViewN/AView Earnings Details
11/3/2014Q115$0.79$0.94$91.40 million$93.40 millionViewN/AView Earnings Details
8/27/2014Q414$0.54$0.64$79.50 million$80.60 millionViewN/AView Earnings Details
5/7/2014Q314$0.60$0.63$84.50 million$80.00 millionViewN/AView Earnings Details
2/6/2014Q214$0.39$0.46$62.21 million$67.30 millionViewN/AView Earnings Details
11/7/2013Q114$0.13$0.22$41.14 million$45.82 millionViewN/AView Earnings Details
9/10/2013Q4 2013$0.07$0.12$37.89 million$40.20 millionViewN/AView Earnings Details
5/8/2013Q3 2013$0.13$0.14$35.14 million$39.00 millionViewN/AView Earnings Details
2/7/2013Q2 2013$0.05$0.10$33.53 million$36.60 millionViewN/AView Earnings Details
11/8/2012Q113$0.05$0.07$33.76 million$35.30 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Lannett (NYSE:LCI)
Current Year EPS Consensus Estimate: $3.4 EPS
Next Year EPS Consensus Estimate: $3.85 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165$0.60$0.91$0.77
Q2 20167$0.62$1.10$0.93
Q4 20163$0.59$0.60$0.60
Q1 20173$0.65$0.73$0.69
Q2 20173$0.80$0.88$0.85
Q3 20173$0.88$0.92$0.90
Q4 20173$0.90$0.95$0.93
(Data provided by Zacks Investment Research)


Dividend History for Lannett (NYSE:LCI)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Lannett (NYSE:LCI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/23/2016Robert EhlingerVPSell37,141$25.06$930,753.46View SEC Filing  
6/20/2016Robert EhlingerVPSell62,859$25.40$1,596,618.60View SEC Filing  
3/1/2016Robert EhlingerVPSell69,247$25.41$1,759,566.27View SEC Filing  
2/5/2016Arthur P BedrosianCEOBuy4,500$24.91$112,095.00View SEC Filing  
2/5/2016David A DrabikDirectorBuy1,277$24.74$31,592.98View SEC Filing  
2/5/2016Kevin SmithVPBuy1,500$24.75$37,125.00View SEC Filing  
2/5/2016Martin P GalvanCFOBuy3,000$24.65$73,950.00View SEC Filing  
9/15/2015Arthur P BedrosianCEOSell5,000$55.64$278,200.00View SEC Filing  
9/8/2015John AbtVPBuy1,000$54.77$54,770.00View SEC Filing  
8/17/2015Arthur P BedrosianCEOSell5,000$52.81$264,050.00View SEC Filing  
7/15/2015Arthur P BedrosianCEOSell5,000$61.92$309,600.00View SEC Filing  
6/15/2015Arthur P BedrosianCEOSell5,000$56.31$281,550.00View SEC Filing  
5/15/2015Arthur P BedrosianCEOSell5,000$53.27$266,350.00View SEC Filing  
4/15/2015Arthur P BedrosianCEOSell5,000$69.43$347,150.00View SEC Filing  
3/16/2015Arthur P BedrosianCEOSell5,000$65.23$326,150.00View SEC Filing  
3/16/2015William SchreckCOOSell134,635$64.99$8,749,928.65View SEC Filing  
3/6/2015William SchreckCOOSell50,000$63.35$3,167,500.00View SEC Filing  
2/18/2015David A DrabikDirectorSell12,500$61.55$769,375.00View SEC Filing  
2/17/2015Arthur P BedrosianCEOSell5,000$59.89$299,450.00View SEC Filing  
2/17/2015G. Michael LandisInsiderSell11,500$58.60$673,900.00View SEC Filing  
2/13/2015Jeffrey FarberDirectorSell35,000$58.18$2,036,300.00View SEC Filing  
2/11/2015Kevin SmithVPSell109,436$56.51$6,184,228.36View SEC Filing  
2/9/2015David FarberMajor ShareholderSell2,500$55.00$137,500.00View SEC Filing  
2/9/2015Kevin SmithVPSell53,534$55.36$2,963,642.24View SEC Filing  
2/6/2015G. Michael LandisInsiderSell12,049$52.93$637,753.57View SEC Filing  
1/26/2015David FarberMajor ShareholderSell7,500$50.00$375,000.00View SEC Filing  
1/15/2015Arthur P BedrosianCEOSell5,000$43.50$217,500.00View SEC Filing  
12/15/2014Arthur P BedrosianCEOSell5,000$43.81$219,050.00View SEC Filing  
12/10/2014Martin P GalvanCFOBuy1,000$42.40$42,400.00View SEC Filing  
12/8/2014Ernest SaboVPSell6,000$48.03$288,180.00View SEC Filing  
10/27/2014David FarberMajor ShareholderSell7,500$50.00$375,000.00View SEC Filing  
9/16/2014Arthur P BedrosianCEOSell5,000$40.05$200,250.00View SEC Filing  
8/18/2014David FarberMajor ShareholderSell5,000$41.30$206,500.00View SEC Filing  
7/15/2014Arthur P BedrosianCEOSell5,000$47.19$235,950.00View SEC Filing  
6/23/2014David FarberMajor ShareholderSell7,500$50.00$375,000.00View SEC Filing  
6/16/2014Arthur P BedrosianCEOSell5,000$46.96$234,800.00View SEC Filing  
6/16/2014David FarberMajor ShareholderSell10,000$43.53$435,300.00View SEC Filing  
6/16/2014Paul TaveiraDirectorSell1,000$46.94$46,940.00View SEC Filing  
3/17/2014William SchreckCOOSell16,600$43.85$727,910.00View SEC Filing  
3/12/2014William SchreckCOOSell55,563$43.31$2,406,433.53View SEC Filing  
2/20/2014Kevin SmithVPSell64,665$45.11$2,917,038.15View SEC Filing  
2/13/2014Kevin SmithVPSell20,000$40.48$809,600.00View SEC Filing  
12/13/2013Arthur BedrosianCEOBuy5,000$27.85$139,250.00View SEC Filing  
12/13/2013Martin GalvanCFOBuy3,000$26.90$80,700.00View SEC Filing  
5/14/2013Kevin SmithVPSell24,984$11.86$296,310.24View SEC Filing  
5/13/2013Kevin SmithVPSell41,929$11.80$494,762.20View SEC Filing  
5/10/2013Ernest SaboVPSell15,000$11.29$169,350.00View SEC Filing  
3/14/2013Paul TaveiraDirectorBuy1,000$9.73$9,730.00View SEC Filing  
2/13/2013Martin P GalvanCFOBuy4,000$6.88$27,520.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Lannett (NYSE:LCI)
DateHeadline logoLannett (LCI): Moving Average Crossover Alert (NYSE:LCI) - August 29 at 10:29 AM logoForget Mylan, Buy These 3 Drug Stocks Instead (NYSE:LCI) - August 26 at 5:44 PM logoClovis Oncology, Inc. (NASDAQ:CLVS), Lannett Co Inc (AMEX:LCI ... - Benzinga (NYSE:LCI) - August 25 at 5:55 PM logoLannett Co., Inc.: Gathering momentum, can it sustain its performance? (NYSE:LCI) - August 25 at 5:55 PM logoLannett Company, Inc. (LCI) Options Volume Explodes On Post-Earnings Gap (NYSE:LCI) - August 25 at 10:59 AM logoLannett Co. (LCI) Rose To A 7-Month High After Q4 Profit Exceeded Expectations (NYSE:LCI) - August 25 at 10:59 AM logoLannett Co., Inc. :LCI-US: Earnings Analysis: 2016 By the Numbers : August 25, 2016 (NYSE:LCI) - August 25 at 10:59 AM logoWednesday's Market Wrap: Stocks Pull Back Mid-Week (NYSE:LCI) - August 24 at 6:54 PM
News IconNotable Stocks on the Move: Lannett Company, Inc. (NYSE:LCI), Capstone Turbine Corporation (NASDAQ:CPST) - NYSE Journal (press release) (NYSE:LCI) - August 24 at 5:47 PM logoWhy Craft Brew Alliance Inc (BREW), Lannett Company, Inc. (LCI) and National Beverage Corp. (FIZZ) Are 3 of Today's ... - (NYSE:LCI) - August 24 at 5:47 PM logoWhy Craft Brew Alliance Inc (BREW), Lannett Company, Inc. (LCI) and National Beverage Corp. (FIZZ) Are 3 of Today’s Best Stocks (NYSE:LCI) - August 24 at 5:17 PM logoWhy Lannett Company, Inc. Jumped Higher Today (NYSE:LCI) - August 24 at 1:57 PM
News IconCrowd & Street Analysis on Lannett Co Inc (NYSE:LCI) - Post News (NYSE:LCI) - August 24 at 9:00 AM logo14 Stocks Moving In Wednesday's Pre-Market Session - Benzinga (NYSE:LCI) - August 24 at 9:00 AM logoLannett Company's (LCI) CEO Arthur Bedrosian on Q4 2016 Results - Earnings Call Transcript - Seeking Alpha (NYSE:LCI) - August 24 at 8:59 AM logoEdited Transcript of LCI earnings conference call or presentation 23-Aug-16 8:30pm GMT (NYSE:LCI) - August 24 at 8:59 AM logoLannett Co. (LCI) Is Rising After Q4 Earnings Topped Expectations (NYSE:LCI) - August 23 at 6:07 PM logoLannett tops Street 4Q forecasts (NYSE:LCI) - August 23 at 6:06 PM logoLannett shares rally more than 10% as results, outlook top Street view (NYSE:LCI) - August 23 at 6:06 PM logoCompany Earnings Report at the Close, Aug. 23 (NYSE:LCI) - August 23 at 10:18 AM logoQ4 2016 Lannett Company Inc Earnings Release - After Market Close (NYSE:LCI) - August 23 at 10:18 AM logoEarnings Whispers: Toll Brothers Inc (TOL) & Lannett Company, Inc. (LCI) - TCC (NYSE:LCI) - August 22 at 5:56 PM logoHere’s The Growth Forecast For Lannett Co Inc (NYSE:LCI) (NYSE:LCI) - August 22 at 10:29 AM logoHere's The Growth Forecast For Lannett Co Inc (NYSE:LCI) - (NYSE:LCI) - August 21 at 5:23 PM logoLannett To Report Fiscal 2016 Fourth-Quarter And Full-Year Financial Results, Host Conference Call On Tuesday, August 23 (NYSE:LCI) - August 17 at 8:57 AM logoLannett Co Inc (NYSE:LCI) Mean Price Target At $29.875 - (NYSE:LCI) - August 8 at 6:07 PM logoLannett Company, Inc. Stock Gained 25.2% Last Month: Here's Why (NYSE:LCI) - August 7 at 8:14 AM logoReview of Analysts Ranking: United Therapeutics Corporation (NASDAQ:UTHR) , Lannett Co Inc (NYSE:LCI) - Street Updates (NYSE:LCI) - August 3 at 6:13 PM logoLannett Co Inc (NYSE:LCI) Quarterly Accounts Payable At $33.038 ... - (NYSE:LCI) - August 2 at 10:44 AM logoResurgence Of Lannett: A Growing Opportunity - Seeking Alpha (NYSE:LCI) - July 31 at 5:34 PM logoResurgence Of Lannett: A Growing Opportunity (NYSE:LCI) - July 30 at 5:24 PM
News IconAre You A Rational Investor? Take This Simple Test (NYSE:LCI) - July 29 at 6:03 PM
News IconLannett (NYSE:LCI) Near to Lift Curtain on June 2016 Earnings - The Voice Registrar (NYSE:LCI) - July 28 at 6:06 PM logoLannett Co Inc (NYSE:LCI) Yearly Accounts Payable At $19.195 ... - (NYSE:LCI) - July 28 at 8:58 AM logoLannett Co Inc (LCI) Shares are Up 7.92% - Trade Calls (NYSE:LCI) - July 25 at 6:03 PM logoLannett Announces Senior Management Promotions (NYSE:LCI) - July 25 at 7:18 AM logoLannett Co Inc (LCI) is Trading Higher on Unusual Volume for July 21 - (NYSE:LCI) - July 22 at 5:50 PM logoOverview of Analysts Suggestions: AbbVie Inc. (NYSE:ABBV) , Lannett Co Inc (NYSE:LCI) - Street Updates (NYSE:LCI) - July 22 at 8:53 AM
News IconLannett Co Inc (NYSE:LCI): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NYSE:LCI) - July 22 at 8:53 AM logoLannett Company, Inc. (NYSE:LCI) Insiders Look Pessimistic About Prospects - Review Fortune (NYSE:LCI) - July 22 at 8:53 AM logoLannett Co Inc (LCI) Jumps 5.13% on July 20 - (NYSE:LCI) - July 22 at 8:53 AM
News IconTelemus Capital buys $177561222 stake in Lannett Company (LCI) - TheFounders Daily (NYSE:LCI) - July 22 at 8:53 AM logoFracking Sand Among Market Hot Spots (NYSE:LCI) - July 21 at 4:25 PM logoTwo Buzzers within Analysts Radar: Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) , Lannett Co Inc (NYSE:LCI) - Street Updates (NYSE:LCI) - July 20 at 4:03 PM
News IconAre Analysts Bearish Lannett Company, Inc. (NYSE:LCI) After Last Week? - Consumer Eagle (NYSE:LCI) - July 20 at 4:03 PM logoLannett Gets FDA Acceptable Filing Letter For Fentanyl Patch ANDA (NYSE:LCI) - July 20 at 9:51 AM logoLannett (LCI) Shares Cross Above 200 DMA (NYSE:LCI) - July 20 at 8:53 AM logoLannett Announces Receipt Of FDA Acceptable Filing Letter For Fentanyl Patch ANDA (NYSE:LCI) - July 20 at 8:53 AM logoLannett Co Inc Common Stock (LCI) Ownership Increased by Telemus Capital, LLC - Finance Daily (NYSE:LCI) - July 19 at 6:01 PM
News IconShares Lower on the Year Lannett Company, Inc. (NYSE:LCI) - Press Telegraph (NYSE:LCI) - July 19 at 12:00 PM


Lannett (NYSE:LCI) Chart for Monday, August, 29, 2016

Last Updated on 8/29/2016 by Staff